Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Bladder disorder? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Bladder disorder have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.0% of all adverse event reports for CABOZANTINIB S-MALATE.

10
Reports of Bladder disorder with CABOZANTINIB S-MALATE
0.0%
of all CABOZANTINIB S-MALATE reports
0
Deaths
5
Hospitalizations

How Dangerous Is Bladder disorder From CABOZANTINIB S-MALATE?

Of the 10 reports, 5 (50.0%) required hospitalization.

Is Bladder disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Bladder disorder?

TERIFLUNOMIDE (393) DALFAMPRIDINE (264) ADALIMUMAB (256) DIMETHYL (237) FINGOLIMOD (215) INTERFERON BETA-1A (194) OCRELIZUMAB (175) LENALIDOMIDE (172) NATALIZUMAB (124) ETANERCEPT (100)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Bladder disorder Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Bladder disorder Reports All Drugs Causing Bladder disorder CABOZANTINIB S-MALATE Demographics